THZ1 can suppress inflammatory genes at the transcriptional level, particularly inhibiting STAT1 and IL-1, therefore, alleviate CRS without impairing the antitumor efficacy [197]. The gene discussed is IL1B; the disease is congenital rubella syndrome.